Evidence map›Paper›PMID 18480460›Full record

ArticleJournal of virology2008

R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.

Silvana Tasca, Siu-Hong Ho, Cecilia Cheng-Mayer

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. CXCR4 Is a Potential Target for Anti-HIV Gene Therapy.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
  4. Predicted coreceptor usage at end-stage HIV disease in tissues derived from subjects on antiretroviral therapy with an undetectable plasma viral load.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2017
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Coreceptor use in nonhuman primate models of HIV infection.Journal of translational medicine · 2011
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Silvana TascaAaron Diamond AIDS Research Center, The Rockefeller University, 455 First Ave., New York, NY 10016, USA.
Siu-Hong Ho
Cecilia Cheng-Mayer
Aaron Diamond AIDS Research Center · USRockefeller University · US

Funding

TRANSMISSION &PATHOGENESIS OF X4 &R5 SHIVSR01AI046980 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI CHENG-MAYER, CECILIA C · 2000 to 2009
$6.0M
Simian Immunodeficiency VIrus PathogenesisR37AI041945 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI CHENG-MAYER, CECILIA C · 2001 to 2010
$5.0M
NIAID NIH HHS R01 AI046980NIAID NIH HHS R01 AI46980NIAID NIH HHS R37 AI041945NIAID NIH HHS R37AI41945NIMHD NIH HHS L60 MD003100
6 · The paper itself

Abstract

To examine the pathway of the coreceptor switching of CCR5-using (R5) virus to CXCR4-using (X4) virus in simian-human immunodeficiency virus SHIV(SF162P3N)-infected rhesus macaque BR24, analysis was performed on variants present at 20 weeks postinfection, the time when the signature gp120 V3 loop sequence of the X4 switch variant was first detected by PCR. Unexpectedly, circulating and tissue variants with His/Ile instead of the signature X4 V3 His/Arg insertions predominated at this time point. Phylogenetic analysis of the sequences of the C2 conserved region to the V5 variable loop of the envelope (Env) protein showed that viruses bearing HI insertions represented evolutionary intermediates between the parental SHIV(SF162P3N) and the final X4 HR switch variant. Functional analyses demonstrated that the HI variants were phenotypic intermediates as well, capable of using both CCR5 and CXCR4 for entry. However, the R5X4 intermediate virus entered CCR5-expressing target cells less efficiently than the parental R5 strain and was more sensitive to both CCR5 and CXCR4 inhibitors than either the parental R5 or the final X4 virus. It was also more sensitive than the parental R5 virus to antibody neutralization, especially to agents directed against the CD4 binding site, but not as sensitive as the late X4 virus. Significantly, the V3 loop sequence that determined CXCR4 use also conferred soluble CD4 neutralization sensitivity. Collectively, the data illustrate that, similar to human immunodeficiency virus type 1 (HIV-1) infection in individuals, the evolution from CCR5 to CXCR4 usage in BR24 transitions through an intermediate phase with reduced virus entry and coreceptor usage efficiencies. The data further support a model linking an open envelope gp120 conformation, better CD4 binding, and expansion to CXCR4 usage.

Indexed as

Amino Acid SubstitutionAnimalsAnti-HIV AgentsHumansMacaca mulattaMembrane GlycoproteinsMutation, MissenseNeutralization TestsPhylogenyPolymerase Chain ReactionReceptors, CCR5Receptors, CXCR4RNA, ViralSequence Analysis, DNASequence HomologySimian Acquired Immunodeficiency SyndromeAnti-HIV Agentsgp120 protein, Simian immunodeficiency virusMembrane GlycoproteinsReceptors, CCR5Receptors, CXCR4RNA, ViralViral Envelope Proteins

Identifiers

PMID18480460
PMCPMC2446975
OpenAlexW2127363544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.